Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-02-28

Clinical Trial Update: Efficacy of Pioglitazone on Microcirculation in Type 2 Diabetes Patients Treated With Insulin [Phase 2]

View source ↗

Summary

Phase 2 trial results evaluating pioglitazone's effect on microcirculation in insulin-treated patients with Type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PIOGLITAZONE (Pioglitazone)

Snippet

Sponsor: Takeda | Conditions: Diabetes Mellitus | Phase 2 | Status: COMPLETED